Galen completes femhrt acquisition
Pharmaceuticals business Galen Holdings has completed the acquisition of femhrt, the hormone replacement therapy.
Galen bought the rights to femhrt from Pfizer.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





